Allogeneic Stem Cell Therapy Market: Introduction

Stem cells are defined as cells that have self-renewing and clonogenic capabilities. These cells can differentiate into multiple cell lineages. Stem cells are basic cells of all multicellular organisms having the potential to differentiate into a range of adult cells. Totipotency and self-renewal are characteristic of stem cells.
Allogeneic stem cell therapy uses cells from a donor. In the most common type of allogeneic transplant, the stem cells are acquired from a donor whose tissue type closely matches that of the patient.
Blood taken from the placenta and umbilical cord of newborns, called cord blood, is a newer source of stem cells for allogeneic transplants. This small volume of blood has a high number of stem cells that tend to multiply quickly.
Researchers are looking for ways to use cord blood for transplants in larger adult population. One approach is to find ways to increase the number of these cells in the lab before transplantation. Another approach is the use of cord blood from two infants for one adult transplant, called a dual-cord-blood transplant.

Report Overview: https://www.transparencymarketresearch.com/allogeneic-stem-cell-the...

Key Drivers of Global Allogeneic Stem Cell Therapy Market

The global allogeneic stem cell therapymarket is primarily driven by increase in the unmet needs in chronic diseases and rise in funding for stem cell research
Presently, several companies are developing a range of tissue engineered products and autologous and allogeneic cell therapies with the objective of bringing about an era of regenerative medicine which is likely to come up with ways to treat people with unmet medical needs
Rise in prevalence of chronic diseases such as cancer and cardiovascular diseases is projected to drive the global allogeneic stem cell therapy market
According to the American Cancer Society, an estimated 1,735,350 new cancer cases were diagnosed in the U.S. in 2018
Moreover, internationally, stem cell research is supported by significant government investments, with Asia being one of the most favorable regions. Stem cell research funding by the National Institutes of Health (NIH) increased by 17% from US$ 1.2 Bn in 2013 to US$ 1.5 Bn in 2016.

Adult Stem Cell Segment Accounted for Major Share of Global Allogeneic Stem Cell Therapy Market

In terms of product type, the global allogeneic stem cell therapy market can be divided into adult stem cells, human embryonic stem cells, induced pluripotent stem cells, and others
The adult stem cells segment is anticipated to dominate the global allogeneic stem cell therapy market during the forecast period
The ability to create trillions of specialized cells is one of the advantages of adult stem cells. These cells could reduce the risk of rejection and repair tissue damage. These factors drive the segment.

Request Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B...

Therapeutics Companies Segment to Offer Attractive Opportunities

Based on end-user, the global allogeneic stem cell therapy market can be classified into therapeutics companies, cell & tissue banks, tools & reagents companies, and service companies
The therapeutics companies segment is expected to account for major share of the global allogeneic stem cell therapy market by 2027
Rise in prevalence of chronic diseases and increase in investment by pharmaceutical & biopharmaceutical companies for stem cell research are the key factors boosting the growth of the therapeutics companies segment

North America to Dominate Global Allogeneic Stem Cell Therapy Market

In terms of region, the global allogeneic stem cell therapy market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period.
Improved investment scenario, high economic growth, rise in prevalence of target chronic diseases, and technological advancements in the region are the key factors driving the allogeneic stem cell therapy market in North America
According to the American Cancer Society, around 1,735,350 new cancer cases were diagnosed in the U.S. in 2018, with 609,640 deaths caused by the disease

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=C...

Key Players Operating in Global Market

Key players operating in the global allogeneic stem cell therapy market are:

Regen Biopharma, Inc.
Escape Therapeutics, Inc.
Cryo-Save AG
Lonza Group Ltd.
Pluristem Therapeutics, Inc.
China Cord Blood Corporation
CBR Systems, Inc.
ViaCord, Inc.

Global Allogeneic Stem Cell Therapy Market: Research Scope

Global Allogeneic Stem Cell Therapy Market, by Product Type

Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Others

Pre Book: https://www.transparencymarketresearch.com/checkout.php?rep_id=7584...

Global Allogeneic Stem Cell Therapy Market, by Application

Regenerative Medicines
Drug Discovery & Development

Global Allogeneic Stem Cell Therapy Market, by End-user

Therapeutics Companies
Cell & Tissue Banks
Tools & Reagents Companies
Service Companies

Global Allogeneic Stem Cell Therapy Market, by Region

North America
S.
Canada
Europe
Germany
France
K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com